BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
토요일, 9월 26

PetMed Express Inc

PETSNASDAQ
Trade with Public
Trade with Public
$1.53
-0.025-1.61%
가까이에: Sep 25, 5:00 PM EST
$1.55
0.02151.41%
시간외: 4:21 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

PetMed Express Analyst Price Targets

Wall Street analyst price targets and consensus rating for PetMed Express (PETS).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Hold
1Sell
Consensus RatingHold# Analysts2Avg. Consensus PT$2Upside to Avg. PT+57.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 25, 2026Morgan StanleyErin WrightPT CutUnderweight$2→$1
Apr 17, 2025Morgan StanleyErin WrightPT CutUnderweight$4→$3
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.
Benzinga Newsdesk

From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026

Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.
Namrata Sen

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $3.5 to $3.2.
Benzinga Newsdesk

PRO
Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5

Lake Street analyst Ryan Meyers downgrades PetMed Express (NASDAQ:PETS) from Buy to Hold and lowers the price target from $7 to $3.5.
Benzinga Newsdesk

PRO
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7

Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $6.5 to $3.5.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved